How Duker was paid
$5.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Jay DukerPresident and Chief Executive Officer | $696,251 | $1,610,700 | $2,604,113 | $632,700 | $24,588 | $5,568,352 |
| George ElstonExecutive Vice President and Chief Financial Officer | $527,677 | $487,340 | $781,234 | $352,148 | $24,977 | $2,173,376 |
| Ramiro RibeiroChief Medical Officer | $505,007 | $487,340 | $781,234 | $359,771 | $23,778 | $2,157,130 |
What changed and why
- $5.6MJay Duker received total compensation of $5,568,352 in fiscal 2025, a decrease from his 2024 total compensation.
- 150%The Compensation Committee approved a corporate performance score of 150% for the year ended December 31, 2025.
- 4%For fiscal year 2026, the Compensation Committee approved salary increases of 4% for Dr. Duker and Mr. Elston and 5% for Dr. Ribeiro.
- 138%Mr. Elston and Dr. Ribeiro received individual performance scores of 138% and 175% for 2025 respectively.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.